2 ms·
>they can at least run it as an RCT. >This combination requires careful monitoring. It appears that the FDA agrees with both of these points and specifically
by s1artibartfast 7y ago
>they can at least run it as an RCT.
>This combination requires careful monitoring.
It appears that the FDA agrees with both of these points and specifically addresses them in the authorization. From the original post:
"The hydroxychloroquine sulfate may only be used to treat adult and adolescent patients who weigh 50 kg or more hospitalized with COVID-19 for whom a clinical trial is not
available, or participation is not feasible."
"Public health authorities about the need to have a process in place for performing adverse event monitoring and compliance activities designed to ensure that adverse events and all medication errors associated with the use of the authorized chloroquine phosphate or hydroxychloroquine sulfate are reported to FDA, to the extent practicable given emergency circumstances"